Catalyst Wire Dossier Catalyst Wire Dossier

CRONILIEF

Palmitoylethanolamide phospholipids
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRONILIEF, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids) in Diabetic Subjects With Neuropathic Pain. [NA]

See pricing